» Articles » PMID: 6276404

Quantitative Resolution of Succinate-cytochrome C Reductase into Succinate-ubiquinone and Ubiquinol-cytochrome C Reductases

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1982 Feb 25
PMID 6276404
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

A purified, active succinate-ubiquinone reductase was prepared from succinate-cytochrome c reductase without damage to ubiquinol-cytochrome c reductase by 1.1% Triton X-100 solubilization at pH 8.0, and calcium phosphate column chromatography in 50 mM Tris-succinate buffer, pH 8.0, containing 30 mM potassium phosphate. Succinate-ubiquinone reductase thus obtained contains ubiquinone and catalyzes thenoyltrifluoroacetone-sensitive oxidation of succinate by 2,6-dichlorophenolindophenol in the absence of exogenous mediator. Addition of ubiquinone enhanced the activity about 50%. Analytical sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that the enzyme contains four polypeptides. The high molecular weight polypeptide contaminants usually observed in the Complex II preparation obtained by the reported method were absent. The active succinate-ubiquinone reductase can reconstitute with the cytochrome b-c1III complex, or Complex III to form succinate-cytochrome c reductase in the absence of exogenous ubiquinone or with the resolved ubiquinol-cytochrome c reductase in the presence of ubiquinone and phospholipids. Under the proper conditions, all the original succinate-cytochrome c reductase was obtained, indicating that the resolution caused no damage to the protein, despite the removal of phospholipids and ubiquinone from the ubiquinol-cytochrome c reductase region.

Citing Articles

Reperfusion mediates heme impairment with increased protein cysteine sulfonation of mitochondrial complex III in the post-ischemic heart.

Chen C, Kang P, Zhang L, Xiao K, Zweier J, Chilian W J Mol Cell Cardiol. 2021; 161:23-38.

PMID: 34331972 PMC: 8629835. DOI: 10.1016/j.yjmcc.2021.07.008.


Data for the synthesis of new 4-aryloxy-N-arylanilines as potent succinate-cytochrome c reductase inhibitors.

Cheng H, Song W, Nie R, Wang Y, Li H, Jiang X Data Brief. 2018; 21:878-881.

PMID: 30426039 PMC: 6223225. DOI: 10.1016/j.dib.2018.10.059.


Oxidative modifications of mitochondria complex II.

Zhang L, Kang P, Chen C, Green K, Chen Y Methods Mol Biol. 2013; 1005:143-56.

PMID: 23606255 PMC: 3774787. DOI: 10.1007/978-1-62703-386-2_12.


Excess no predisposes mitochondrial succinate-cytochrome c reductase to produce hydroxyl radical.

Chen J, Chen C, Alevriadou B, Zweier J, Chen Y Biochim Biophys Acta. 2011; 1807(5):491-502.

PMID: 21406178 PMC: 3698227. DOI: 10.1016/j.bbabio.2011.03.001.


Design and use of peptide-based antibodies decreasing superoxide production by mitochondrial complex I and complex II.

Kang P, Yun J, Kaumaya P, Chen Y Biopolymers. 2010; 96(2):207-21.

PMID: 20564035 PMC: 2965271. DOI: 10.1002/bip.21457.